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ABSTRACT  
Objective: A receptor binding assay for detection of saxitoxin, a paralytic shellfish poisoning toxin, was formatted for use in a high throughput 
detection system using microplate scintillation counting. The RBA technology was transferred from the NOAA National Ocean Service, SC USA, to 
the Thailand Institute of Nuclear Technology, which uses a Perkin Elmer Microbeta TriLux 1450 microplate scintillation counter. Methods: Validation 
of method was performed by participating in the regional inter-laboratory program. The result yielded all parameters within the critical control point 
(i.e. RSD less than 30%). Results: The slope of the calibration graph = 1.2 + 0.26 (RSD = 21.7%) (criteria = 0.8 - 1.2), half maximal inhibition (IC50) 
= 3.1 + 0.47 nM (RSD = 15.2%) (criteria = 3.0 nM), dynamic range = 1.2 - 10 nM and the limit of detection (IC80) from graph = 1.2 nM, equivalent 
to the limit of quantification of 2.57 mg/100 g shellfish. The result of analysis of unknown samples yielded the RSD between assays ranging from 6 - 
23% and the recovery compared to the expected value ranging from 79 -133%. The application of RBA for determination of PSP in shellfish samples 
yielded RSD in assays less than 30% and between assays ranging from 1.4-15.2%. Conclusion: RBA for STX has showed a valuable for rapid, 
reliable, cost-effective alternative to live animal testing and high throughput screen prior to testing by the conventional mouse bioassay (MBA) and its 
suitability for providing an early warning of increasing PSP toxicity when toxin levels are below the MBA limit of detection. 
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Introduction 
§The paralytic shellfish poisoning (PSP) syndrome is 
caused by the consumption of shellfish containing high levels 
of saxitoxin (STX) (Figure 1) and its numerous analogs. 
Toxicity of saxitoxin has been reported in many countries 
such as USA, Canada, Japan, Australia, New Zealand, 
Malaysia, the Philippines and Thailand1,2,3 and Southeast 
Alaska4,5. In human, recognizable PSP symptoms include 
tingling and numbness of peripheral area and extremities, 
following ingestion of about 0.72 mg STX equivalents; while 
severe intoxication include respiratory paralysis and possible 
death, resulting from the exposure to 0.9 - 3.6 mg STX 
equivalents. Renal clearance of the toxin from the blood is 
completed within 24 hours6.  
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Figure 1 Structure of saxitoxin (STX).  
 
These PSP toxins exploit the highly specific interaction 
with their biological receptor, i.e. voltage-dependent sodium 
channel, specifically site 1 of α-subunit7. The assay on STX 
is thus based on functional activity rather than antigenic 
determinant8. This receptor binding assay provides a 
radioactive endpoint, and is performed in a microtiter filter 
plate format with results determined by liquid scintillation 
counting. The Ki for the assay is 3.66 ± 0.86 nM saxitoxin, 
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with a limit of detection of 5 ng saxitoxin/ml in a sample 
extract8. 
The mouse bioassay (MBA) has historically been the 
most universally applied technique for examining shellfish, 
especially for PSP. However, MBAs have some limitations 
including low sensitivity, somewhat large variability of test 
results (±20%)8, the use of large numbers of live animals, 
and the resulting toxicity measure of all toxins combined 
instead of individual toxins. Furthermore there are some 
critics of the mouse toxicity method from animal protection 
group6,8,9.  
In recent years, considerable effort has been applied to 
development of chemical assays to replace these bioassays. 
As a result, a good high performance liquid chromatography 
(HPLC) coupled with post-column electrochemical oxidation 
procedure has been developed to identify individual PSP 
toxins10. Nevertheless HPLC technique was not sufficiently 
rapid or robust to handle a large number of samples 
generated during bloom events and the system requires a 
considerable amount of skill and dedicated time to make it 
operate routinely11. Numerous other techniques have been 
examined as possible replacements including receptor 
binding assay (RBA)12,13, enzyme immunoassays14,15, bio-
sensor technology16 and neuronal network17. Among these 
methods, RBA is considered a very promising alternative to 
the mouse bioassay.  
The RBA technique employs the microplate scintillation 
technology8,12. It expresses PSP toxin concentrations in nM 
STX equivalents; while in the MBA method, concentrations 
are expressed in μg STX equiv./100 g shellfish toxin6. 
Theoretically, RBA is a functional assay based on the toxins 
with their pharmacological receptors and gives a measure of 
toxic potency. RBAs are appropriate for those toxin classes 
that interact with membrane receptors, including the voltage 
dependent sodium channel and are the method of choice 
when a rapid, high throughput measure of total toxic potency 
is desired. RBA is carried out by incubating the known 
receptor for the toxin (R), in the presence of the radiolabeled 
toxin analog (T*) which together form a radiolabeled receptor 














Figure 2 Receptor-toxin complex (a) and associating 
competition curve between labeled and unlabeled 
toxin (b). Note: T = unlabeled toxin, T* = radiolabeled toxin, 
T*R = radiolabeled–receptor complex, R = receptor and TR = 
unlabeled–receptor complex.   
  
With the addition of unlabeled toxin (T) to this incubation 
mixture, in the form of toxin standard or unknown sample, 
the unlabeled toxin competes with the radiolabeled toxin for 
the receptor, forming unlabeled complex (TR). The amount 
of radiolabeled complex formed in this mixture is quantified 
by liquid scintillation counting. With increasing amount of 
unlabeled toxin, the amount of radiolabeled complex 
decreases relatively to the amount of radiolabeled complex 
formed in the absence of unlabeled toxin. This competition 
between labeled and unlabeled toxin for the receptor 
generates a competition curve which can then be used to 
quantify the amount of toxin present in an unknown sample.  
The objectives of this research were to establish a 
laboratory with its ability to perform RBA for determination of 
PSP toxins especially saxitoxin, and to produce a ready-to-
use radiolabeled kit for STX toxicity in seafood with a high 
throughput screening for STX.   
 
Materials and Methods  
Materials   
Chemicals and equipments with their sources were as 
follows: Motorized tissue homogenizer, high speed centrifuge 
with rotor, centrifuge tubes, 1 and 8 channel micropipettes, 
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MOPS (UltraPure, BioBasic); choline chloride (Sigma);  
phenyl methylsulfonyl fluoride (PMSF) (Sigma); bicinchoninic 
acid protein assay (BCA) kit (Novagen); 96-well microtiter 
filter plate; Multiscreen vacuum manifold (Millipore); micro-
plate reader with 562 nm wavelength (Tecan); microplate 
scintillation counter (Perkin Elmer Microbeta TriLux 1450); 
saxitoxin reference standard (STX dihydrochloride) (NRC, 
Canada), 3H-STX (I.I.C.H., USA); Optiphase cocktail (Perkin 
Elmer); shellfish samples; Wistar rat brains (6 weeks old 
male rats, National Animal Center, Mahidol University); 
absorbent toweling, disposable bench paper; curve-fitting 
software package (Graph Pad Prism).   
 
Methods   
A) Sample Preparations  
• Samples collection  
Shellfish samples were collected in March 2008, in Gulf 
of Thailand by Department of Marine Coastal Resources. 
Each sample was weighed and measured for its length and 
homogenized with blender. Samples were frozen imme-
diately after transferred to TINT laboratory on ice, and stored 
at –20 °C until analyzed for the presence of toxin by 
receptor binding assay.   
 
• Samples extraction 
Samples were homogenized with blender then accurately 
weighed for 5.0 g and put into a conical tube. The sample 
was added with 3.0 ml of 1% acetic acid, mixed on vortex, 
heated in water bath for 5 minutes, then capped loosely to 
avoid pressure buildup. The sample was removed from 
water bath, mixed on vortex mixer, let cool to room 
temperature, and centrifuged for 10 minutes at 4,500 rpm. 
Finally supernatant in conical tube was collected. The solid 
residue in the original tube was added with 3.0 ml of 1% 
acetic acid, mixed well on vortex mixer and centrifuged for 
10 minutes at 4,500 rpm. This supernatant was collected 
and combined with the first portion. The combined 
supernatant was mixed and diluted to 6 ml with ddH20, and 
centrifuged to clarify supernatant and transferred to a new 
tube. The sample extract was stored at -80 °C until assay. 
 
• Preparation of rat brain membrane 
Medulla and cerebellum from rat brain was removed. The 
brain (cerebral cortex) was placed in a small amount of 100 
mM MOPS/100 mM choline chloride/0.1 mM PMSF buffer, 
pH 7.4 in a petri dish which was placed on ice. In a glass 
tube, 25 ml of MOPS/choline chloride/PMSF buffer and 2 
cerebral cortices were put in, then homogenized at 3,000 
rpm with 20 up and down strokes or more, if necessary. 
There should be no chunks left in the homogenate. The tube 
was kept in ice at all times. Homogenized tissue was poured 
into a beaker on ice and the procedure was repeated with 
remaining cortices. This pooled homogenized tissue was 
transferred to centrifuge tubes balanced with ice cold buffer, 
then centrifuged at 20,000 xg for 15 min at 4 °C. 
Supernatant was aspirated and discarded. Re-suspend pellet 
was pooled in ice cold MOPS/choline chloride/PMSF buffer. 
The centrifuge was thoroughly rinsed with a small amount of 
buffer and the rinsed sample was pooled in pool in beaker. 
For each brain sample, a final volume of 10 ml was made 
using buffer solution while kept on ice. This pooled 
homogenized tissue was transferred to a glass tube, 
homogenized at 3,000 rpm with 10 up and down strokes or 
more, if necessary. This homogenized tissue was then 
poured into a beaker and stirred with magnetic bar on ice 
with a low speed. The preparation was then aliquoted for 1 
ml per tube into microtubes or cryotubes on ice and stored 
at -80 °C. This preparation was stable for at least 6 months.  
 
• Protein determination in rat membrane by BCA 
protein assay kit  
Rat brain membrane was removed for determination of 
protein concentration by BCA protein assay kit. The method 
was performed according to manufacturer’s instructions 
(BCA protein assay kit 71285-3, Novagen). The protein 
concentration (in stock 1 ml/tube) was approximately 7.315 
mg/ml. The stock rat membrane preparation was diluted 1:8 
in ice cold assay buffer (100 mM MOPS/100 mM choline 
chloride buffer, pH 7.4) to yield a final protein concentration 
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B) The Assay Procedure  
• Preparation of Stock Solution and Standards for Assay  
♦ Assay buffer solution (100 mM MOPS/100 mM 
choline chloride buffer, pH 7.4)  
MOPS of 20.9 g and choline chloride of 13.96 g were 
added to 900 ml ultra pure H20 or ddH20 for a buffer with pH 
of 7.4 while stirring with 0.1 N HCl or 0.1 NaOH. The final 
volume of 1 L was made with ultra pure H20 or ddH20. 
 
♦ Radioligand solution  
3H-STX stock solution was provided in 50 μCi/ampoule, 
21 Ci/mmol, or 0.1 mCi/ml. This was equivalent to 4.17 μM.  
a) 3H-STX working solution: The solution of 15 nM 3H-
STX was freshly prepared from 3H-STX stock solution for 
each assay daily. Fifteen μl of stock 3H-STX solution was 
transferred and 4.155 ml assay buffer was added and mixed 
with vortex mixer. Since specific activity of 3H-STX usually 
varied between lots, the calculation on concentration was 
required and the volume used for dilution was adjusted 
accordingly.  
b) Total radioactivity measurements on each working 
solution prior to the assay: Fifty μl of Optiphase® cocktail 
was added to 35 μl of working solution. Using liquid 
scintillation counter, the radioactivity count should be at least 
1,000 counts. The count measurement was performed to 
determine if the isotope was degrading over time relative to 
the initial value and/or to detect an incorrect dilution.  
 
♦ Unlabelled STX reference standard preparation  
STX standard was provided at a concentration of 268.8 
μM (100 μg/ml). Serial dilutions for the standard curve were 
prepared as shown in Table 1. These STX standards could 
be prepared in advance and stored at 4 °C for 1 month.   
 
• Determination of Tissue Linearity 
Dilutions of membrane preparation were made at 1/4, 
1/8, 1/16, 1/32, 1/64 in assay buffer. 140 μl of each dilution 
was added to triplicate wells of 96-well microtiter filter plate 
containing 35 μl assay buffer and 35 μl 3H-STX working 
solution. The plate was covered and incubated at 4 °C for 1 
h to achieve equilibrium binding. The mixture was then 
filtered using a Multiscreen vacuum manifold system. The 
count was carried out using microplate scintillation counter.  
Counts per minute (CPM) against dilutions was plotted to 
determine the maximum dilution that gave adequate binding 
(≥ 1000 CPM), such that a minimum number of membrane 
preparation was used in each assay. This dilution had to be 
on the linear part of the curve.  
  
 
Table 1 Serial dilutions for standard curve of saxitoxin (STX).   
STX standard (M) 0.003 M HCl (ml) Final concentration (M) In assay* concentration (M) 
A 100 μl 268.8 μM STX 4.38 6x10-6 1x10-6 
B 500 μl from tube A 4.5 6x10-7 1x10-7 
C 1.5 ml from tube B 3.5 1.8x10-7 3x10-8 
D 500 μl from tube B 4.5 6x10-8 1x10-8 
E§ 500 μl from tube C 4.5 1.8x10-8 3x10-9 
F 500 μl from tube D 4.5 6x10-9 1x10-9 
G 500 μl from tube F 4.5 6x10-10 1x10-10 
H 500 μl from tube G 4.5 6x10-11 1x10-11 
Ref 0 5.0 0 Reference 
* All standards were diluted 1:6 in the assay (35 μl standard in 210 μl of total reaction mixture). 
§ Inter-assay calibration standard: A reference standard containing 1.8x10-8 M STX standard. It was dispensed with 120 μl in a 0.5 ml microtube for 20 microtubes and stored 
at -80 0C. It was critical that aliquot was thawed and kept on ice before use. This served as a quality control for the day-to-day performance of the assay. 
 
 
C) Performing the Assay 
Standards and samples were run in triplicate. Samples 
were undiluted and diluted 1:2 with assay buffer (1 part 
sample + 1 part assay buffer) (see Table 2 for plate layout). 
Rat brain membrane preparation was thawed and kept on 
ice. Membrane preparation was diluted at 1:8 with ice cold 
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assay buffer (one part of membrane + 7 parts of buffer). 
Diluted membranes were kept on ice until used. Each of the 
following was added to each of the 96-wells microfilter plate; 
35 μl STX standard or QC or sample, 35 μl 3H-STX, 140 μl 
rat brain membrane preparation (equiv. 0.128 mg protein). 
All were then covered and incubated at 4 °C for 1 hour. 
After that, 96-well plate was placed on the multiscreen 
vacuum manifold and empty wells of the plate were filled 
with 210 μl of assay buffer.  
The vacuum was run until liquid was removed. Each well 
was rinsed twice with 210 μl ice cold assay buffer using 8 
multichannel pipettor, then the plastic bottom was removed 
from the plate. The plate was blotted on absorbent toweling 
and bottom of counting cassette was sealed with sealing 
tape and microplate was placed in a counting cassette. Fifty 
μl Optiphase cocktail was added to the wells using 8 
multichannel pipettor. The plate was sealed with sealing tape 
and allowed to sit for 30 minutes at room temperature and 
then counted in microplate scintillation counter (1 minute per 
well).    
   
D) Data Analysis    
Curve fitting was carried out using Graph Pad Prism® 
software in the one-site receptor competition assay mode. 
The concentration of PSP toxins( in nM STX equivalent) in 
the sample was determined from a competitive binding curve 
generated by transforming the percent total binding data 
(B/B0) using a logit transformation and graphing the result 
values on a linear y-axis scale against a logarithmic x-axis 
scale of the unlabelled STX concentration. The best-fitted 
line was generated using a non linear regression, and the 
STX concentrations in the unknown sample were obtained 
by solving the regression equation for (x) using the logit 
transformation of B/Bo for the sample (y). Sample 
concentration was then calculated in μg STX equivalents/100 
g shellfish, using the following formula: 
 
 
Table 2 Plate layouts.  
 1 2 3 4 5 6 7 8 9 10 11 12 
A 10-6 M 10-6 M 10-6 M Ref Ref Ref Sam 4 Sam 4 Sam 4 Sam 8 Sam 8 Sam 8 
 












C 3x10-8 M 3x10-8 M 3x10-8 M Sam 1 Sam 1 Sam 1 Sam 5 Sam 5 Sam 5 Sam 9 Sam 9 Sam 9 
 


















E 3x10-9 M 3x10-9 M 3x10-9 M Sam 2 Sam 2 Sam 2 Sam 6 Sam 6 Sam 6 Sam 10 Sam 10 Sam 10 
 


















G 10-10 M 10-10 M 10-10 M Sam 3 Sam 3 Sam 3 Sam 7 Sam 7 Sam 7 Sam 11 Sam 11 Sam 11 
 


















Note: Sam = sample; The standard curve may be used for multiple plates.   
 
  (nM equiv STX) x (sample dilution) x (210 μl total volume)  =  nM equiv STX in extract           (1) 
                                                        35 μl sample 
 
  (nM equiv STX in extract)  x    1  L     x     372  ng   x    1 μg     =   μg STX equiv/ml             (2) 
              1000 ml         nmol          1000 ng 
 
  μg STX equiv/ml  x        ml extract           x   100      =       μg STX equiv     (3)  
                           g shellfish extract                        100 g shellfish    
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E) Assay Quality Control  
This process consisted of 3 critical control points. First, 
for a ligand which interacted specifically at one receptor site, 
the slope of the resulting competition curve should 
theoretically be 1.0. If the slope of the curve for a given 
assay was outside of the acceptability range of 0.8 - 1.2, 
linearity of the assay would be compromised and 
quantitation of the unknowns would be incorrect. Therefore, 
the assay should be re-run. Second, the QC check standard 
should fall within ±30% of the stated value of 3.0 nM (2.1 - 
3.9 range). If the QC check standard did not fall within an 
acceptable limit of 2.1-3.9, the assay should be re-run. 
Third, the following criteria must be met for acceptability of a 
sample measurement. 1) Sample quantification should be 
done only on dilutions that on the linear part of the curve 
(B/Bo = 0.2 - 0.7). 2) In the event that no sample dilutions 
fell within the linear range (i.e., concentration was too high, 
or B/Bo < 0.2), further dilution must be made and the sample 
reanalyzed. In the event that the sample concentration is too 
low to be quantified (i.e. B/Bo > 0.7), the sample must be 
reported as below limit of detection. 3) The % relative 
standard deviation (RSD) of calculated value must be less 




Based on CPM vs. dilutions plot, the dilution at 1/8 was 
the maximum dilution that gave adequate binding (≥ 1,000 
CPM) and easy to filter from multi-screen vacuum manifold 
(data not shown).  
 
 
Validity of the method  
The test of validity was done by running the assay on 7 
unknown samples provided by National Oceanic and 
Atmospheric Administration (NOAA), USA. The assays were 
run in triplicate, at 3 dilutions on 3 different days. The 
calibration curve is shown in Figure 3. All parameters fell 
within the acceptable critical points for quality control on the 
method: i.e., IC 50 = 3.1 + 0.47 nM (RSD = 15.2%); slope = 
-1.2 + 0.26 (RSD = 21.7%); and dynamic range = 1.2 - 10 
nM (b/b0: 0.2 - 0.8). Limit of quantification was found on the 
linear part of the curve (b/b0: 0.2 - 0.8) as follows:   
 
LOD  = IC 80 = 1.2 + 0.04 nM 
LOQ  = 1.2 * 6 (assay dilution) * 5 (sample dilution) = 36 nM  
36 nM  = 13.17 ng/ml = 2.57 μg/100g 
 













Figure 3 Calibration curve from 3 assays run on 3 different 
days. Conditions: [3H- STX] 1.5 nM, FDA di HCl reference 
standard, crude rat brain membrane, microplate assay 
format, Perkin Elmer Microbeta TriLux 1450.  
    
Linearity of the method was found from the plot of the 
measured values vs. the expected values of STX 
concentrations (Figure 4). The curve shows a high 




Figure 4 Plot of expected vs. measured STX concentrations 
showing a linearity of the RBA method.  
 
 
The results of inter-comparison exercises compared to 
the expected values were shown in Table 3. All results 
exhibited good precision with the RSD between assays of 
less than 30%, and acceptable accuracy with the recovery 
varied from 79% to 133%.  
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Application of RBA technique on the determination of 
PSP in samples  
Shellfish samples from Gulf of Thailand were determined 
for PSP using a typical run of the receptor binding assay 
protocol. The concentration of PSP toxins (in μg STX equiv. 
/100 g sample) was determined using the Prism software 
(GraphPad Software Inc.) The analytical results are shown in 
Table 4. All results were acceptable with RSDs in assay of 
less than 30% and RSDs between assays ranging from 
1.4% to 15.2%.  
 
Discussion and Conclusion  
The RBA technique is a competitive binding assay based 
on pharmacological properties of PSP toxins. Because the 
affinity of binding to their biological receptor is directly 
proportional to the toxic potency of the PSP toxins, 
measurements based on sodium channel binding yield a very 
 
 
Table 3 Results of inter-comparison exercises of RBA techniques compared to the expected values.  
 Assay 1 Assay 2 Assay 3 Mean SD % RSD Expected % Recovery 
QC 3 3 4 4 1 23 3 133 
RR1 39 41 35 38 3 7 46 83 
RR2 346 547 479 457 102 21 480 95 
RR3 515 540 667 574 81 14 715 80 
RR4 569 519 654 581 69 13 518 112 
RR5 <DL <DL <DL <DL 0 0 0 100 
RR6 317 347 369 344 26 6 438 79 
RR7 108 110 123 114 8 8 104 110 
Note: RR = shellfish homogenates; QC = Quality control; DL = Detection limit.    
 
 .    
 
Table 4 PSP toxicity (as STX equivalent) in shellfish samples.  
Sample 











μg STX equiv./100g 
shellfish 
1 B-BTB-08-03-13-1 1 33.121 198.726 10 5.04 0.074 14.668 
  1/2 13.028 156.336 10 5.04 0.058 11.539 
2 R-MK-08-03-04-1 1 1.305 7.830 10 5.08 0.0029 0.573 
  1/2 0.584 7.008 10 5.08 0.0026 0.513 
3 H-MK-08-03-04-1 1 0.388 2.328 10 4.98 0.0009 0.174 
  1/2 0.207 2.484 10 4.98 0.0009 0.186 
4 G-BT-08-03-25-1 1 4.231 25.386 10 5.02 0.0094 1.881 
  1/2 2.347 28.164 10 5.02 0.0105 2.087 
5 O-BT-08-03-25-1 1 1.771 10.626 10 5.05 0.0040 0.783 
  1/2 0.957 11.484 10 5.05 0.0043 0.846 
6 G-BT-08-03-24-1 1 9.059 54.354 10 5.03 0.0202 4.020 
  1/2 5.096 61.152 10 5.03 0.0227 4.523 
7 O-AS-08-03-24-1 1 0.643 3.858 10 5.05 0.0014 0.284 
  1/2 0.273 3.276 10 5.05 0.0012 0.241 
8 G-BS-08-03-24-1 1 1.579 9.474 10 5.05 0.0035 0.6979 
  1/2 0.581 6.972 10 5.05 0.0026 0.5136 
9 G-TK-08-03-19-1 1 19.34 116.04 10 5.19 0.0432 8.317 
  1/2 7.123 85.476 10 5.19 0.0318 6.127 
10 O-PD-08-03-18-1 1 3.345 20.07 10 4.99 0.0075 1.496 
  1/2 1.626 19.512 10 4.99 0.0073 1.455 
* The sample was run with no dilution and with a 1:2 dilution. All RSDs of calculated values were less than 30%. The quality control check standard on 3 
assays was 2.482, 2.537 an d 2.695 nM, respectively, with the value of 3.0 nM.  
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accurate estimate of sample’s overall toxicity. In the RBA 
method, tritiated STX (3H-STX) and unlabeled toxin (STX) in 
the form of standard or sample compete for available 
receptors contained in a rat brain membrane preparation. 
The extent of radiolabeled receptor-toxin complex formation, 
which is inversely proportional to the amount of unlabeled 
toxin present, is determined by the detection of tritium, a low 
energy beta emitter (18.6 keV), using the highly sensitive 
and reliable liquid scintillation counting method.   
Compared with the MBA, where external factors such as 
the health of the mice can affect the measures and the 
response is from a gross measurement (death time), the 
RBA is dependent on the receptor-based toxic activity and 
radioisotopic counting statistics. Thus, the RBA method can 
be considered a more refined technique with enhanced 
specificity, precision, and high sensitivity. Although the MBA 
has been reliable as an indicator of human oral potency, it 
cannot predict a bloom in advance because of its low 
sensitivity. The limit of detection for The MBA is 40 μg STX 
equiv/100g shellfish tissue, a level only two-fold less than the 
federal action level of 80 μg STX equiv/100g shellfish tissue, 
the point that harvesting of shellfish is prohibited. In contrast 
the limit of detection for The RBA is 0.2 μg STX equiv/100g 
shellfish tissue; this method is therefore capable of detecting 
the early stages of toxic algal blooms.6 Thus, RBA for PSP 
has showed a valuable for rapid, reliable, cost-effective alter-
native to live animal testing and high throughput screening -
prior to testing by the conventional mouse bioassay (MBA) 
and its suitability for providing an early warning of increasing 
PSP toxicity when toxin levels are below the MBA limit of 
detection.8  
This study showed the validity of method on 
determination of PSP as STX equivalent in shellfish samples 
based on linearity, precision, accuracy and limit of 
quantification. The results from analyzing 7 unknown 
samples in triplicate in three different days revealed a high 
linearity with R2 of 0.9964, RSD in assay of < 30%, a 
recovery ranging from 79 % to 133% and a limit of 
quantification of 2.57 μg STX equiv. /100 g shellfish. Based 
on 10 shellfish samples from the Gulf of Thailand, the result 
showed a good precision with RSDs between assays of 1.4 - 
15.2%. In this study all shellfish samples collected from Gulf 
of Thailand showed low levels of STX, which were less than 
the maximum tolerance levels established by the European 
Union and the Food and Drug Administration (40 - 80 μg per 
100 g edible portion of fresh, frozen, or tinned shellfish).15 
Based on the purpose of our institute, to promote the usage 
of radioisotope technique in marine biotoxins assay in 
Thailand, we thus have chosen the radioisotope technique to 
determine STX in shellfish extracted samples. In conclusion, 
we successfully set up a Marine Biotoxins Laboratory in 
TINT and produce a new radiolabeled kit to detect STX in 
Thailand with a high throughput screening for STX according 
to France van Dolah experience and her previous report.8,18  
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